Single ventricle heart defects are among the most serious congenital heart diseases, and are uniformly fatal if left untreated. Typically, a three-staged surgical course, consisting of the Norwood, Glenn, and Fontan surgeries is performed, after which the superior vena cava (SVC) and inferior vena cava (IVC) are directly connected to the pulmonary arteries (PA). In an attempt to improve hemodynamic performance and hepatic flow distribution (HFD) of Fontan patients, a novel Y-shaped graft has recently been proposed to replace the traditional tube-shaped extracardiac grafts. Previous studies have demonstrated that the Y-graft is a promising design with the potential to reduce energy loss and improve HFD. However these studies also found suboptimal Y-graft performance in some patient models. The goal of this work is to determine whether performance can be improved in these models through further design optimization. Geometric and hemodynamic factors that influence the HFD have not been sufficiently investigated in previous work, particularly for the Y-graft. In this work, we couple Lagrangian particle tracking to an optimal design framework to study the effects of boundary conditions and geometry on HFD. Specifically, we investigate the potential of using a Y-graft design with unequal branch diameters to improve hepatic distribution under a highly uneven RPA/LPA flow split. As expected, the resulting optimal Y-graft geometry largely depends on the pulmonary flow split for a particular patient. The unequal branch design is demonstrated to be unnecessary under most conditions, as it is possible to achieve the same or better performance with equal-sized branches. Two patient-specific examples show that optimization-derived Y-grafts effectively improve the HFD, compared to initial nonoptimized designs using equal branch diameters. An instance of constrained optimization shows that energy efficiency slightly increases with increasing branch size for the Y-graft, but that a smaller branch size is preferred when a proximal anastomosis is needed to achieve optimal HFD.
Introduction
The Fontan procedure is the third stage of the palliative surgical course for single ventricle heart patients [1] . The first stage, the Norwood procedure, channels aortic flow to the pulmonary arteries (PAs) via a systemic to pulmonary shunt or right ventricle to pulmonary artery conduit. In the second stage, the bidirectional Glenn procedure, the superior vena cava (SVC) is disconnected from the right atrium and reimplanted into the PAs. In the third and final stage, the Fontan procedure, the inferior vena cava (IVC) is connected to the PAs either via an extracardiac Gore-Tex tube or a lateral tunnel. Deoxgenated blood is passively channeled to the PAs and the single functional ventricle is used to pump oxgenated blood flow to the body following Fontan completion.
Despite high early survival rates (90%) following the Fontan procedure, the 5-year survival rate drops to about 80% and the long-term outlook is still unsatisfactory, with complications including protein losing enteropathy, arteriovenous malformations, thrombosis, arrhythmias, and heart failure [2, 3] . Pulmonary arteriovenous malformations (PAVMs), characterized by abnormal communication (i.e., short circuit) between the pulmonary arteries and pulmonary veins, are a serious complication, occurring in as many as 25% of patients with superior cavopulmonary anastomosis due to the exclusion of hepatic blood flow from the pulmonary circulation [4] . Patients with PAVMs may subsequently develop cyanosis, congestive heart failure, and respiratory failure [5] . Although the cause of PAVMs is not fully understood, clinical evidence shows that the absence of a hepatic factor carried in the IVC blood is a likely cause. While the incidence of PAVMs decreases after Fontan completion, they may still persist or develop due to skewed hepatic flow distribution, particularly in patients with heterotaxy and interrupted IVC [6] [7] [8] . PAVMs can be resolved by surgical correction of uneven hepatic flow distribution (HFD) [7] [8] [9] . Thus, it is desirable to carefully consider the post-operative HFD in surgical planning in order to reduce the risk of PAVMs and the need for surgical re-intervention.
While most previous studies on Fontan hemodynamics have focused on energy loss [10] [11] [12] [13] , recent studies have shown increased interest in quantifying HFD [14] [15] [16] [17] [18] [19] . Recently a new Yshaped graft design in which the left and right PAs (LPA and RPA) are anastomosed to a bifurcated conduit has been proposed to replace conventional tube-shaped extracardiac grafts [17, 20] . A study of Soerensen et al. [20] proposed a dual bifurcated graft using an idealized model. The first patient specific Y-graft study of Marsden et al. [17] showed improved energy efficiency and HFD in a single patient study. Following this, the study of Yang et al. [19] demonstrated improved hemodynamic performance of the Y-graft in multiple patient models. However, the use of a nonoptimized design resulted in underperforming Y-graft designs in two out of five patient-specific models [19] . Automated shape optimization was applied to the Y-graft design using an idealized model to reduce energy loss in a study of Yang et al. [21] . However, formal shape optimization has not previously been applied to improve HFD. Preliminary results have shown that the Fontan connection geometry is a critical determinant of HFD [19] . Thus, the impact of Fontan geometry and flow conditions on HFD, and methods to improve underperforming designs merit further exploration.
In this study, we couple shape optimization to HFD quantification to systematically improve Y-graft performance. The goals of this study are (1) to evaluate a new Y-graft design with unequal branch sizes, (2) understand the influence of flow splits on choice of optimal Y-graft, (3) examine the effect of SVC flaring, and (4) improve HFD in previously underperforming Y-grafts. To achieve this, we couple Lagrangian particle tracking to a derivative-free optimization framework for cardiovascular geometries introduced by Marsden and co-workers [21, 22] to optimize HFD in Y-graft models. Because patients often present clinically with uneven pulmonary flow splits, due to differing pulmonary resistances and lung sizes, we identify optimal designs for a range of flow conditions. While a 55/45 (RPA/LPA) ratio is commonly accepted [17, 23] , Seliem et al. [24] observed that 35% of patients immediately prior to Fontan have a moderate to severe uneven pulmonary flow distribution ranging from 28% to 2% flow to one lung. In agreement with this, moderately uneven pulmonary flow distribution was found in two out of five Glenn patients in our previous studies [19, 25] . To achieve optimal HFD in these patients, we hypothesize that unequal Y-graft branch sizes may be needed. Simple conservation of mass analysis [19] demonstrates that a 50/50 hepatic flow split is not possible in patients with a highly uneven overall pulmonary flow split. We therefore identify the best theoretical distribution for each pulmonary flow split scenario, and set that as our target for optimization. In addition, the theoretical analysis shows that HFD also depends on the IVC/SVC flow ratio. Thus, the impacts of IVC/SVC flow ratio on the optimal shapes are studied in idealized and patient-specific models. Since the SVC-to-PA anastomosis may play an important role in flow interaction [19] , we also investigate the effects of the SVC anastomosis on the choice of optimal graft design. Two patientspecific models with underperforming Y-grafts are optimized to improve skewed HFD using surrogate management framework (SMF). In addition, constrained optimization was performed on a semi-idealized Fontan model to study the impact of applying HFD constraint when optimizing for energy efficiency [21] .
Methods
This study is divided into two parts. In the first part, we optimize an idealized Fontan model to identify optimal shapes for even HFD with variations in the pulmonary flow split, IVC/SVC flow ratio, and SVC-to-PA anastomosis geometry. In the second part, we present two patient-specific examples to demonstrate that optimization-derived designs effectively improve the HFD in cases that were previously underperforming.
Geometrical Model Construction
2.1.1 Idealized Cases. Models were constructed using a customized version of the Simvascular software framework [26, 27] . The construction of the idealized models follows our previous work in which an automated script is used to generate the model given a set of geometric input parameters [21] . We first generate centerlines of the model ( Fig. 1 upper left) and then loft circles along the centerlines. Since we have hypothesized that unequalsized branches may be necessary to improve HFD, we also allow branch diameters to vary independently in the model during optimization ( Fig. 1 upper right) , resulting in seven design parameters for this case. Design parameters used to define the Y-graft design space include the branch diameters D R and D L , the distances between the branch anastomosis and the SVC X R and X L , the branch curvatures D R and D L , and the trunk length L IVC . In addition, there are six constant parameters used to define the dimensions of the IVC trunk, PA and SVC [21] . In the Glenn procedure, the SVC is connected to the PA in an end to side fashion. The anastomosis may be flared to direct flow preferentially to one lung or the other or, in preparation for the subsequent Fontan procedure [25, 28] . To study the influence of the SVC geometry on the choice of optimal graft design, we replace the regular SVC-PA junction in selected models with two representative cases: (1) LPA-flared junction ( Fig. 1 bottom left) and (2) curved junction ( Fig. 1 bottom right) .
Patient-Specific Cases.
Since previous patient-specific studies [19, 29] have shown large variations in PA topology, the idealized model ( Fig. 1 ) constructed for general analysis cannot sufficiently represent a specific patient's geometric and hemodynamic characteristics. We therefore optimized a semi-idealized model that incorporates key features of the patient specific model, and then use a patient-specific model for final verification.
For each patient, we create a semi-idealized model (Fig. 2) as follows. The patient-specific centerline path of the PA with circular segmentations and the patient's SVC are incorporated into the semi-idealized Glenn model to preserve each patient's main geometric characteristics (Fig. 2) . The PA diameter is set to an average measured from the patient-specific Glenn model. Then, a Ygraft is implanted into the Glenn model to form a semi-idealized Fontan model for optimization.
The optimization for these cases only included designs with equal-sized branches, which reduced the number of design parameters to four ( Fig. 2 ): X L , X R , L IVC , and D branch . For the PA path, we can define a parametric spline
such that the center of each PA segmentation lies on the curve. Thus, design parameters X L and X R are a function of parameter t.
To determine the bounds of X L and X R , the aortic arch and previous nonoptimized patient specific models constructed under the guidance of a surgeon were used as a reference. The parameter bounds are listed in Table 1 . In this study, we use the terms "proximal" and "distal" to describe the anastomosis location relative to the SVC. The anastomosis points (marked with solid squares in Fig. 2 ) are allowed to slide along the PA path within the bounds. Similarly, the path of the Y-graft is defined by a Hermite spline. Based on surgical practice at our institution, the PA at the anastomosis will be enlarged to match the graft size when a large graft is anastomosed to the PA and pressurized. For example, in measurements taken from images of a post-operative Fontan patient who had a 20 mm extracardiac conduit placed, the size of the PA at the anastomosis was about 19 mm. To account for this change, the circular segmentations along the PA path are adjusted automatically when the branch size is larger than the PA size. First, the segmentation at the anastomosis point is enlarged to the graft size. Then the rest of the PA segmentations are enlarged linearly according to the distance to the closest anastomosis. The two outlets of the PA are kept unchanged.
To improve initially underperforming Y-grafts, we first optimize the Y-graft in the semi-idealized model. After an optimal Ygraft is identified, we implant it into the patient-specific model to verify the hemodynamic performance. The semi-idealized model for patient A was chosen for a constrained optimization example with energy efficiency as the cost function and HFD as the constraint.
Flow Simulation and Boundary Conditions.
A custom stabilized finite element Navier-Stokes solver [30] was employed to simulate blood flow, assuming rigid walls and Newtonian flow with a density of 1:06 g=cm 3 and viscosity of 0.04 g/(cm s). Anisotropic mesh adaptation based on the Hessian of the velocity field was performed for the patient-specific models, to ensure mesh convergence of the solution [31] .
Pulsatile inflow conditions were employed for the IVC and SVC inlets with a parabolic profile. A respiratory model was superimposed on the IVC flow waveform acquired from PCMRI for each patient following our previous work [13] . No respiratory model was added to the SVC input because little respiratory variation is typically found in the SVC flow [13, 32] . The mean flow rates for inlets are listed in Table 2 .
Although 3D flow simulations can provide detailed flow information, it is impossible to include the entire arterial system in the 3D simulation. Therefore a 0D model (lumped element model) was coupled to the outlets of the 3D flow solver to account for the influence of the downstream vasculature. Resistance boundary Table 1 Bounds on the design parameters for the semiidealized model. X R and X L are measured from the SVC-PA junction to the right and left anastomosis points, respectively. Since the PA path is a parametric spline SðtÞ, the anastomosis location can be changed by varying the spline parameter t. In our previous study [19] , patient specific models employed a uniform 20-15-15 mm Y-graft. To optimize the graft size, the branch diameter was allowed to vary between 12 and 16 mm. Table 2 Mean pulsatile inflow rates, pulmonary flow splits and pressure. A respiratory model [13] was superimposed to the IVC flow acquired from PCMRI for each patient following our previous work. No respiratory model was added to the SVC input. The flow rates used for the idealized model were taken from a typical Fontan patient [13, 25] . We varied the RPA/LPA flow split in the idealized model for different conditions and set a Fontan pressure (central venous pressure) of 12 mmHg. For patients A and B, pulmonary flow splits and pressure data were taken from MRI and catheterization prior to the Fontan procedure. Transpulmonary gradient (TPG) is the mean pressure difference between the SVC and the left atrium [25] . conditions were employed for the idealized and semi-idealized models. For a given pulmonary flow split, resistance values (R ¼ P=Q) were determined by setting 12 mmHg as the mean Fontan pressure, a typical clinical value. For patient-specific simulations, a three element RCR circuit model [33] was applied at each outlet. Total resistance was tuned to match the MRI-derived pulmonary flow split and catheterization-derived transpulmonary gradient (TPG) ( Table 2 ), assuming that the pre-Fontan outlet boundary conditions are still valid for immediate post-operative flow conditions [19, 25] . The proximal and distal resistances and capacitance for each outlet were determined based on a morphometry-based pulmonary arterial tree and outlet areas [25] .
Resistances for each patient's semi-idealized model matched the total LPA and RPA resistances of the corresponding patientspecific model.
Quantification of HFD.
Using conservation of mass, we derive the following formula for the HFD:
where Q is the flow rate, F RPA is the fraction of total inflow going to the RPA, H RPA is the fraction of hepatic flow going to the RPA, and S RPA is the fraction of SVC flow going to the RPA. We assume that hepatic flow is well mixed in the IVC such that the hepatic and IVC flow distributions are the same, and that the theoretical optimal HFD is the closest value to 50/50. Based on Eq. (2), the theoretical optimum for the HFD can be obtained for any combination of the pulmonary flow split and IVC-to-SVC flow ratio, as shown in Fig. 3 . The fraction of SVC flow going to the RPA, S RPA , is allowed to change between 0 and 1 to achieve the best HFD. A few conclusions can be drawn from Eq. (2) and For an IVC/ SVC ratio of 1, the theoretical optimum is 50/50 for a percentage inflow to the RPA between 25% and 75%.
A particle-tracking method [16, 17] was used to quantify the HFD in 3D simulations. Approximately 10000 massless particles were released uniformly at the inlet of the IVC every 1/100th of the respiratory cycle for an entire cycle. Calculating particle flux gives the hepatic flow streaming to the RPA and LPA. We confirmed that final results were not sensitive to the seeding density and rate [17] and were consistent with conservation of mass (Eq. (2)).
2.3 Optimization Algorithm. SMF [34] together with mesh adaptive direct search (MADS) [35] is employed for optimizing HFD, following the work of Dennis, Audet, and Marsden [21, 22, 36] . We consider the optimization problem, minimize JðxÞ subject to x2X; CðxÞ 0 where J: R n ! R is the cost function, X & R n denotes the feasible region, and x is the vector of parameters. The constraints are given by m functions c i :
., m such that CðxÞ ¼ (c 1 ðxÞ; …; c m Þ
T . The cost function J for unconstrained optimization is defined as
where H RPA is the fraction of IVC flow going to the RPA. For a given x, J is obtained by performing a 3D simulation and particle tracking. We optimize the HFD to achieve a target flow split of 50/50. For cases in which the theoretical optimum is not 0.5, the best cost function value is therefore larger than zero. The SMF consists of search and poll steps. First, we evaluate a set of design points given by Latin hypercube sampling (LHS) to construct an initial surrogate model. The parameter space is discretized into a mesh and all points subsequently evaluated by the algorithm are restricted to lie on this mesh. At each iteration, the search and poll steps are executed alternately, depending on whether an improved design point was found in the previous iteration. In the search step, the minimum of the current surrogate function is evaluated. Search steps will stop when they fail to find an improved point, at which time a poll step is performed. In the poll step, a set of positive spanning directions formed by points neighboring the current best point is evaluated [35] . 2), the theoretical optimum for the HFD, defined as the value closest to 50/50, is determined given an inflow ratio Q IVC =Q SVC and a pulmonary flow split F RPA (% inflow to RPA).
If the poll step is successful, the algorithm returns to the search step. If the poll step fails to find an improved point, the mesh is refined and the algorithm resumes with a search step. A minimum mesh size is set by the user as the criterion to terminate the optimization, and in our case we stop after one refinement due to computational cost considerations. The initial mesh resolution in the parameter space is less than 0.5 cm. The poll step guarantees convergence to a local minimum [36, 37] . Here, surrogates are constructed using standard Kriging, and polling is done using MADS [36, 38] .
The optimization framework developed in [21, 22] automates each step including model generation, meshing, flow simulation, and post-processing. The particle tracking code is incorporated into the post-processing step in this work for the first time.
For the constrained case, we define a cost function J based on energy efficiency [13] and an HFD constraint C as follows:
where E effic is given by
where u is the velocity, p is the pressure, q is the density, and A i is the area of the ith inlet or outlet. SMF with a filter method is used to perform constrained optimization [39] . A filter formed by undominated points is updated as the SMF algorithm proceeds. Point x is undominated if there is no evaluated point x 0 , such that Cðx 0 Þ CðxÞ and Jðx 0 Þ JðxÞ. The criterion for a successful search or polling in the constrained optimization is an identification of new undominated points. We refer the reader to the work of Audet and Dennis on a pattern search filter algorithm for details [21, 22, 39] .
Results

Idealized Cases.
We first examine the question of whether unequal sized branches may be advantageous to improve HFD for cases of highly uneven pulmonary flow split. To mimic an uneven pulmonary flow split, the LPA/RPA resistance ratio was set to 4. In the first case, we allowed branch diameters to vary independently during optimization to determine if unequal branches are needed to achieve optimal performance. In subsequent tests, we restricted the number of design variables to use equal-sized branches only and kept boundary conditions unchanged to determine whether unequal-sized branches are the only way to achieve optimal HFD. Figure 4 shows that shape optimization for a case with a highly uneven pulmonary flow split 79/21 (RPA/LPA) caused a large difference in the optimal branch diameters. The branch size for the RPA reduced to the lower bound, increasing resistance for IVC flow streaming to the RPA. In contrast, optimization results for the case of equal-sized branches achieved almost the same optimal HFD, with a 9% smaller energy loss. In addition, outflow rates in both cases were almost unchanged, confirming that the overall pulmonary flow split is largely determined by the outlet boundary conditions, and not the local geometry.
These initial results suggested that unequal-sized branch diameters were unnecessary for achieving optimal HFD. To further confirm this hypothesis, we optimized the idealized model with equal-sized branches over a large range of pulmonary flow splits. Figure 5 shows that the theoretical optima for the pulmonary flow splits we tested are achieved, and the optimal geometry depends on the pulmonary flow split. We observe that anastomosis locations were more distal on the side of higher pulmonary resistance.
The shape optimization of the Y-graft was also performed for two different SVC flaring configurations. Figure 6 shows the optimal Y-grafts for these two flared SVC anastomoses and a straight anastomosis under the same flow split conditions. While the optimal geometry for the straight SVC connection is almost symmetric, the optimal geometry for both flared configurations is asymmetric with the RPA connection more proximal, and the LPA connection more distal. These differences in geometry result from SVC streaming to the LPA side in case of a flared SVC anastomosis. Since the HFD is also a function of the IVC/SVC flow ratio, we altered the ratio without changing the cardiac output to examine the impact on different models. Figure 7(a) shows that the idealized Y-graft model is insensitive to changes in this ratio. However, the changes in the IVC/SVC flow ratio can significantly influence the HFD in a patient-specific model due to a more complex flow field.
Patient-Specific Cases.
To test the ability of optimization to improve hepatic flow in a patient specific model, we now present the results for patient specific optimization using a semiidealized model. Figure 8 shows that the optimal Y-graft identified via a semi-idealized model for patient A resulted in a consistent HFD after it was implanted into the patient-specific Glenn model. Compared to the original nonoptimized design, the HFD is improved by 79% and the left branch anastomosis in the optimal design is more proximal. With a more proximal anastomosis of the Y-graft to the RPA, the SVC flow suppressed hepatic flow, reducing its concentration in the RPA to a balanced level. An additional optimization case for patient A was run in which a uniform PA diameter was used. When the resulting optimal Y-graft was implanted into the patient specific model, there was no improvement in HFD.
In patient B, the right upper lobe (RUL) is adjacent to the SVC. In our first optimization run, the RUL was not included in the semi-idealized model for optimization and the target HFD was set to 50/50 as before. Figure 9 shows that the target optimal Y-graft made no improvement in the patient-specific model even though it achieved the target value in the semi-idealized model. By The idealized Y-graft is optimized for an IVC inflow-to-total inflow ratio of 45%. There is only 1% change in the Y-graft model when the ratio is altered. However, the patient specific model is more sensitive to the change of IVC inflow-to-total inflow ratio. examining each outflow rate, we found that the flow to the RUL accounted for 15% of the RPA outflow. Since the RUL mainly received flow from the SVC, the concentration of SVC flow in the RPA flow was sensitive to the presence of the RUL. To compensate for the presence of the RUL in the semi-idealized model, the target hepatic flow split value was changed to 0.65 in the second optimization run. Figure 10 shows that a Y-graft that achieved a hepatic flow split of 65/35 in the idealized model successfully distributed hepatic flow evenly when it was implanted to the patientspecific model. In the resulting model, the right anastomosis is Fig. 9 Time-averaged velocity vector fields in the semi-idealized and patient-specific models with and without the RUL for patient B. The Y-graft is optimized for an HFD of 50/50. Due to the effect of the RUL, the optimized Y-graft skewed the hepatic flow by around 15% after it was implanted into the patient-specific model. When the RUL is excluded from the patient-specific model, the HFD is consistent with the idealized model prediction. more distal, while the left one is more proximal in the optimized model and the branches have less curvature in the optimized design compared to the previous one. Table 3 lists geometric parameters and power loss for patient specific models. A smaller branch size resulted in more power loss in both patients.
Results for the constrained optimization are shown in Fig. 11 . Although no design with a hepatic flow split of 50/50 was identified, the least infeasible design, which is similar to the optimized design in Fig. 8 , violated the HFD constraint by only 1%. Among all undominated points, energy efficiency increased with increasing branch size at a price of sacrificing even HFD.
Discussions
By coupling particle tracking to an optimization framework, we optimized a series of Y-graft designs to achieve optimal HFD in different scenarios. In idealized cases, the unequal branch design was optimized and compared to the equal branch design. Results showed that unequal branches are not necessary to achieve an even HFD in all cases that we evaluated. We studied the impacts of the pulmonary flow split, IVC/SVC flow ratio, and SVC flaring on the choice of the optimal Y-graft. Again, the Fontan connection geometry played an important role in distributing the hepatic flow. Two previously underperforming patient-specific Y-graft designs were improved by optimizing semi-idealized models with the patients' SVC and PA paths and then implanting the optimal design into the corresponding patient specific model.
Idealized Cases.
We have previously observed that Ygraft designs with equal-sized branches resulted in skewed hepatic flow in some patient-specific models. To have greater control over hepatic distribution, we hypothesized that unequal branches might improve distribution in select cases, particularly for patients with highly uneven right/left pulmonary resistances. In this study, we tested this hypothesis using an idealized model with a right/left pulmonary flow split close to 80/20 and compared to results for equal-sized branches. Optimization with and without unequal branches were both shown to achieve the target optimal hepatic distribution. However, designs with unequal branches dissipated more energy due to a higher pressure drop in the smaller branch. Although reducing the branch size on one side can increase the resistance to that side, our results showed that changes in the branch geometry had little-to-no influence on the overall pulmonary flow split. More importantly, the use of unequal-sized branches had limited impact on the HFD, while the anastomosis locations had a significant impact. Thus, for models with a normal pulmonary flow split around 45/55, equal-sized branches can easily achieve the target optimal flow distribution through a proper choice of anastomosis locations and branch curvature. In addition, graft Table 3 Geometric parameters and power loss for patient specific models. In patient A, the optimal X R was reduced resulting in a more proximal anastomosis for the right branch. In patient B, the right anastomosis is more distal while the left one is more proximal in the optimized model. In both cases, a smaller branch size resulted in more power loss designs with unequal branch diameters may increase difficulties in manufacturing compared to equal-sized branches. Thus, the equal-sized branches should be suitable for most cases regardless of the pulmonary flow split. Since patients often come in with a range of relative blood flow distribution, our intent was to explore this range of starting conditions for Y-graft implantation. For patients with widely unequal pulmonary flow distribution, we identified a series of optimal Y-graft designs in which the theoretical optimal HFD is achieved over a large range of pulmonary flow splits. Results show that the optimal anastomosis location depends on the pulmonary resistances for the corresponding side. For a fixed IVC/ SVC ratio, if the inflow received by the RPA is reduced, one needs to reduce the SVC flow that goes to the RPA to keep an even HFD (Eq. (2)). This can be achieved by modifying the Ygraft such that its implantation facilitates flow from the IVC to the RPA. This thus leads to a more distal anastomosis of the graft to the RPA, which streams IVC flow towards the RPA, the branch with higher resistance. Therefore, the PA with lower resistance requires a more proximal anastomosis, while the PA with higher resistance requires a more distal anastomosis. In addition, HFD is more sensitive to the anastomosis location than the branch size.
During the Glenn procedure, some surgeons flare the SVC towards the LPA intending to channel more SVC flow to the LPA which usually has a higher resistance than the RPA [25, 28] . However the pulmonary flow split is dictated by the downstream resistance, and thus the distribution of SVC flow is equal to the pulmonary flow split in the Glenn. After Fontan completion, SVC geometry may play an important role in determining HFD. We performed Y-graft optimization for two types of flared SVC anastomoses. For both flared geometries, the resulting optimal designs had a more distal branch anastomosis on the LPA side compared to the straight SVC case. This can be explained by the fact that flaring to the LPA increases SVC flow to the LPA. Hence, according to Eq. (2), to maintain the optimum HFD for given flow split and IVC/SVC flow ratio, SVC flow to the RPA needs to be facilitated. This can be achieved either by impeding IVC flow to the RPA (leading to a more proximal anastomosis on that side) or by facilitating IVC flow to the LPA (leading to a more distal anastomosis on that side). The latter case lead here to the optimum solution. Compared to the flared SVC case, the curved SVC anastomosis channeled more SVC flow to the LPA for most Ygrafts evaluated during the optimization and required about 200% more evaluations to achieve the theoretical optimum. The relative pulmonary blood flow in the Glenn patient plays a significant role in subsequent Fontan blood flow distribution and, as such, consideration should be given to measuring this routinely in preoperative Fontan patients. In addition, surgeons should carefully consider the specifics of the anastomosis for the SVC-PA junction in the Glenn procedure with an eye towards the impact on the HFD in the Fontan procedure. For example, if a patient has an RPA/LPA flow split of 80/20, it would be preferential to have most of the SVC flow going to the RPA when the IVC is connected to the PA in order to optimize hepatic flow split. If the Glenn, however, had the SVC-PA anastomosis flared towards the LPA, a Y-graft that achieves the target HFD would be difficult.
We also studied the effect of changing the IVC/SVC flow ratio on HFD in both idealized and patient-specific models. In the idealized case, for a Y-graft optimized for a certain IVC/SVC flow ratio, the HFD remains almost unchanged when the IVC/SVC ratio is altered. However, a patient specific model is more sensitive to changes in IVC/SVC flow. A possible reason is that the Y-graft in this patient-specific model has proximal anastomoses. The trend is qualitatively consistent with the change from rest to exercise, which was observed in our previous study [19] , in which increasing the IVC flow momentum improved the HFD. Thus a significant change in IVC flow momentum directly influences the SVC-IVC flow interaction. These findings indicate that the idealized model is not sufficient for capturing this sensitivity.
Patient-Specific Cases.
In patient A, we demonstrated that the patient's PA path and size should be included in the semiidealized model to achieve consistent predictions when the graft design is implanted in the patient specific model. Since optimization involves systematically evaluating a series of designs, the use of idealized models can significantly reduce overall computational cost. Simulations for a patient specific model are 15 times more expensive than for a semi-idealized model. However, without proper consideration, an oversimplified model may be lacking important local information and result in a failed prediction. Direct patient-specific shape optimization requires a methodology solution to parameterize and automatically manipulate the graft anastomosis. At the present time, it remains a challenge to parameterize patient-specific models, due to the need for manipulating a complex surface while maintaining its integrity using relatively few design variables. In the future, a fully parameterized patient specific model could serve as a high fidelity model and a multifidelity optimization could be performed with a low-fidelity semi-idealized model [40] .
In patient B, the importance of including the RUL when computing the HFD was revealed. In the model for patient A, the RUL flow was lumped together with the RPA when constructing the semi-idealized model. However, the same approach did not prove adequate for patient B because the RUL attachment point was on the SVC. Results showed flow streaming from the SVC to the RUL with very little mixing and less than 1% of hepatic flow delivered to the RUL. Therefore the presence of the RUL directly influenced the concentration of SVC flow in the RPA outflow. In contrast, including or excluding the RUL will not produce significant differences in the HFD if the RUL is distal to the SVC. Thus, for patients with a direct RUL-SVC connection, the semiidealized model must compensate for the RUL flow contribution, as done in patient B. The extra hepatic flow going to the RPA in the semi-idealized model would be offset when the same Y-graft was implanted into the patient-specific model with the RUL.
In patient A, without optimization, HFD is too skewed towards the RPA. According to the semi-idealized simulations, the Y graft can achieve better HFD either with a more proximal anastomosis on the RPA side (to reduce IVC flow to the RPA) or a more distal anastomosis on the LPA side (to favor IVC flow towards the LPA). Indeed, the optimized geometry leads to a more proximal anastomosis on the RPA side. On the other side, due to geometric constraints, the anastomosis could not be placed more distally. To compensate, the diameter was decreased to favor hepatic flow to the LPA. By contrast for patient B, optimization needed to increase IVC flow to the RPA. Here, the optimum was found by using a more proximal anastomosis on the LPA side (impeding IVC flow to that side) and increasing the graft diameter (facilitating flow to the RPA). The complex interplay of the 3D geometry and flow is highlighted in these patient specific cases, where identification of optimum configurations requires computer simulations using the full model. Very recently, Haggerty et al. [41] reported simulation results for five Y-graft Fontan patients showing a similar relationship between the graft anastomoses and HFD. In their study, a proximal or medial anastomosis on the PA side with a lower resistance value resulted in even HFD around 50/50 while a distal anastomosis away from the SVC jet channeled more hepatic flow [41, 42] .
No consistent choice for optimal branch size was observed when HFD was optimized without constraints. Patient A's optimal branch size (12.9 mm) was smaller than the nonoptimized size (15 mm) while a larger diameter (16 mm) was identified for patient B. This can be attributed to the existence of multiple local minima. The trunk length had a variable influence on HFD with no particular trend for the values considered. The anastomosis locations for the Y-graft play a more important role than the trunk length in regulating HFD. However, an instance using constrained optimization for energy efficiency with an HFD constraint showed that energy efficiency slightly increased with increasing branch size, but that large branches are disadvantageous when a proximal anastomosis is required to achieve optimal HFD. Haggerty et al. [41] showed that Y-graft connections generally do not differ from the traditional designs in terms of the TCPC resistance. We believe that the branch size and trunk length may have a pronounced impact on wall shear stress (WSS) levels in the graft. Future work should consider thrombotic risk in the surgical design, and thus a further study with WSS and residence time constraints is warranted.
Sundareswaran et al. [43] correlated the TCPC resistance with cardiac index using lumped parameter models, but a recent multiscale modeling study by Baretta et al. [44] showed the choice of Fontan geometry has negligible effect on cardiac work load. While these results suggest that energy loss may be less significant than previously thought, further studies with multiple patients are needed to elucidate how clinical outcomes correlate with hydrodynamic energy loss or TCPC resistance.
Technical Considerations for Y-Graft Implantation.
Space constraints are the main concern for surgical implantation of the Y-graft. Since 20 mm grafts with an offset are routinely implanted in our institution, our surgeons maintain there should be enough space for a Y-graft with 12 or 14 mm branches. The space available, however, can vary dramatically from patient to patient, making some patients better candidates than others. The Y-graft may also not be applicable to patients with abnormal anatomy and/or a history of clotting disorder. Special care should be taken for these patients to identify an optimal graft prior to surgery. Recently, technical feasibility with 18 Â 9 Â 9 mm and 20 Â 10 Â 10 mm Y-grafts has been demonstrated by Kanter et al. [42] showing even HFD was achieved by distal and tangentially aligned anastomoses for the branches.
Limitations.
A HFD of 50/50 is assumed to be optimal in this study, and all Y-graft designs are evaluated according to this criterion. Although the exact value required for the prevention of PAVMs is still unknown, the goal of distributing hepatic flow evenly is supported by clinical practice. As a step towards a better understanding of the relationship between Fontan geometry and HFD, we chose 50/50 as a reasonable target value which could be adjusted in future studies. In addition, since patients with heterotaxy and IVC interruption have a higher risk of PAVMs, an optimal design exclusively for patients with heterotaxy and prePAVMs merits serious consideration in future studies.
In this study, a single objective optimization with a simple bound constraint was performed. However it is clear that surgical design is multifactorial and physiological states can change over time. In addition, discrepancies from surgical implementation may result in a large deviation in post-operative performance. Multiple objectives, constraints and robustness should be addressed in future studies [45] .
For the idealized model, the Y-graft is restricted to lie in a plane. Additional variables for future study could include out-ofplane anastomosis angles and trunk size to increase design flexibility though as mentioned previously, space within the chest cavity is limited. The geometry of the SVC-PA junction should be examined in future studies to determine if the Glenn procedure should be performed differently in patients with a planned Y-graft procedure.
Our assumption that the PA is enlarged to accommodate a large graft anastomosis is based on common surgical practice. The work of Dobrin et al. [46] showed that the maximum size of the anastomosis is determined by the Gore-tex graft because the arteries are much more compliant than the Gore-tex material. Although we do not model the process of vessel enlargement in this study, models are constructed under the guidance of a surgeon to replicate realistic anastomoses. Future work will focus on incorporating finite element modeling into the model construction, such that the process of anastomosing the graft in patient-specific models can be implemented automatically.
The HFD is quantified numerically. Although the flow solver that provides velocity fields for particle tracking has been validated against experiments and theoretical solutions, predictions of the patients' HFD still need to be validated in vivo and in vitro. Patients' lung perfusion data will be used to compare with numerical simulations in our future work, and comparisons to in vitro models should also be made.
In this study, the HFD was divided into two parts (IVC-RPA and IVC-LPA). However, we found that little hepatic flow was delivered to the RUL in patient B though the overall hepatic flow split is close to 50/50. It is still unknown whether an overall even hepatic flow split with a localized lack of hepatic flow in a lobe can cause PAVMs. Future work would look at the incidence of PAVMs in the RUL and consider controlling the HFD for each lobe.
A rigid wall assumption is used in this study. Our recent work has demonstrated that HFD is insensitive to the use of rigid versus deformable walls, which increased confidence in our HFD predictions [47] . However future predictions of thrombotic risk linked to wall shear stress will likely require fluid structure interaction, as there are large differences in WSS between rigid and flexible wall simulations.
For the patient specific cases, flow measurements were taken from preoperative PCMRI data. Although we accounted for changes in IVC inflow patterns after the Fontan procedure by scaling the IVC waveform, a multiscale closed loop model [44] should be incorporated in future studies.
Conclusion
In this study, we coupled Lagrangian particle tracking to an optimization framework to investigate the effect of geometry on HFD in a Y-graft Fontan configuration. Y-graft models with unequal-sized branches were compared to models with equalsized branches. Optimized models with equal-sized branches are able to distribute hepatic flow equally well as unequal-sized branches with lower energy loss under highly uneven pulmonary flow split conditions. In addition, the theoretical optima are achieved using equal-sized branches over a large range of pulmonary flow splits. Thus we do not recommend unequal-sized branches for future Y-graft designs. A flared SVC anastomosis impacts optimal geometry of the Y-graft by resulting in a more distal anastomosis for the branch on the flared side and a more proximal one on the other side compared to the nonflared case. In idealized models, the Y-graft design is more robust to changes in the IVC/SVC flow ratio than the offset design. However, a patient-specific test did not support this finding.
Two underperforming Y-grafts have been successfully optimized for patient-specific cases by using semi-idealized Glenn models that incorporated key patient-specific attributes, namely a patient-specific SVC and a curved PA path. Compared to the original designs, these optimized Y-grafts for patients A and B improved HFD by 79% and 94%, respectively. The strategy of using semi-idealized models for optimization avoids a costly trialand-error design process, requiring laborious manual model revisions. A smaller branch size is preferred when a proximal anastomosis is needed to achieve optimal HFD despite a slight decrease in energy efficiency. We also found that ignoring the effect the right upper lobe when it is adjacent to the SVC may result in failure to improve HFD in patient-specific models. This study emphasizes that an optimization plan should be tailored for each patient within the context of the overall framework we have presented.
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